HomeOpen Access NewsNeurodegenerative Diseases

Neurodegenerative Diseases

Gene therapy shows a breakthrough in slowing Huntington’s disease progression

A new gene therapy called AMT-130 has shown promising results in slowing the progression of Huntington’s disease, according to the latest results from a global clinical trial.

Regenerative therapies for multiple sclerosis: Clues from studying normal brain development

Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, walks us through regenerative therapies for multiple sclerosis, including comment on clues from studying normal brain development.

JPND: Towards a stronger brain health partnership

One of JPND’s key objectives is to fortify its work in brain health partnerships in Europe to better combat the challenges of neurodegenerative disease (ND).

Cerebral creatine deficiency syndrome through genetic treatments

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, addresses cerebral creatine deficiency syndrome through genetic treatments.

The prevalence of Brittle Bone Disease

Dr Roger J. Young, Professor at Saba University School of Medicine, walks us through Brittle Bone Disease, otherwise known as Osteogenesis Imperfecta Type I.

Cellular & biological pathways from studies on communicable diseases

Adonis Sfera and Zisis Kozlakidis provide recent insights into cellular and biological pathways from studies on communicable diseases.

Understanding the brain: hope for neuroscience research

Advancing neuroscience research improves quality of life for all people with neurological disorders, and ultimately can prevent or cure these diseases. Open Access Government highlight some research priorities in neuroscience.

Epilepsy, brain tumours and pioneering neurosurgery

Maxine Smeaton, Chief Executive of Epilepsy Research UK delves into the common yet complex connections between brain tumours and seizures.

JPND: Neurodegenerative disease research without boundaries

Jacqueline Hoogendam, JPND’s newly elected Vice-Chair and Executive Board member talks about JPND’s past and present strategies in its outreach campaign within and beyond Europe.

What happens to our brains when we multitask?

The Del Monte Institute for Neuroscience have been shedding light on how health brains are able to multitask while walking

New gene-silencing drug could help with ALS

New research suggests that in suppressing a mutated ALS gene, it may be possible to delay to onset of symptoms.

COVID brain impact similar to Chronic Fatigue Syndrome

It is now well-known that the virus can create severe respiratory issues - but the impact of COVID on the brain is an equally important, unanswered question.

Could we treat psychiatric disorders with ultrasounds?

Research has found that low-intensity transcranial ultrasound stimulation can modulate brain activity and behaviours, supporting the observations of psychiatric conditions.

Genetic disease treatment research for creatine deficiency

Professor Olivier Braissant, believes there is hope for the treatment of creatine deficiency thanks to new genetic disease research - here, he tells us all about the recent developments.

Scientists find that expectations influence pain intensity

The study found that expectations of how painful something will be, actually changes how the pain feels.

Scientists find molecular reason for creation of chronic pain

A new study finds the exact molecular mechanism that turns acute pain into chronic pain - a condition that leads to the use of opioids and often, lifelong addiction.

Scientists reveal how the brain creates motivation

The study, published in PLoS Biology, looked at the neurotransmitter in the brain that calculates whether to pursue a task - in other words, motivation.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders